TR200201245T2 - Kanser tedavisi için onkolitik kombinasyonlar. - Google Patents

Kanser tedavisi için onkolitik kombinasyonlar.

Info

Publication number
TR200201245T2
TR200201245T2 TR2002/01245T TR200201245T TR200201245T2 TR 200201245 T2 TR200201245 T2 TR 200201245T2 TR 2002/01245 T TR2002/01245 T TR 2002/01245T TR 200201245 T TR200201245 T TR 200201245T TR 200201245 T2 TR200201245 T2 TR 200201245T2
Authority
TR
Turkey
Prior art keywords
cancer treatment
oncolytic
combinations
oncolytic combinations
ltb4
Prior art date
Application number
TR2002/01245T
Other languages
English (en)
Turkish (tr)
Inventor
Herbert Fleisch Jerome
Stuart Benjamin Roger
Scott Sawyer Jason
Ann Teicher Beverly
Wade Beight Douglas
C. R. Smith Edward
Thomas Mcmillen William
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of TR200201245T2 publication Critical patent/TR200201245T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
TR2002/01245T 1999-11-11 2000-11-09 Kanser tedavisi için onkolitik kombinasyonlar. TR200201245T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16478699P 1999-11-11 1999-11-11

Publications (1)

Publication Number Publication Date
TR200201245T2 true TR200201245T2 (tr) 2004-08-23

Family

ID=22596085

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01245T TR200201245T2 (tr) 1999-11-11 2000-11-09 Kanser tedavisi için onkolitik kombinasyonlar.

Country Status (22)

Country Link
EP (1) EP1231938A2 (es)
JP (1) JP2003513916A (es)
KR (1) KR20020069512A (es)
CN (1) CN1390139A (es)
AR (1) AR032432A1 (es)
AU (1) AU778829B2 (es)
BR (1) BR0015490A (es)
CA (1) CA2391416A1 (es)
CZ (1) CZ20021551A3 (es)
EA (1) EA200200545A1 (es)
HK (1) HK1050132A1 (es)
HU (1) HUP0204449A3 (es)
IL (1) IL148579A0 (es)
MX (1) MXPA02004733A (es)
NO (1) NO20022245L (es)
NZ (1) NZ517667A (es)
PE (1) PE20010701A1 (es)
PL (1) PL355172A1 (es)
SK (1) SK6492002A3 (es)
TR (1) TR200201245T2 (es)
WO (1) WO2001034137A2 (es)
ZA (1) ZA200202822B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034197A2 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
US6797723B1 (en) 1999-11-11 2004-09-28 Eli Lilly And Company Heterocycle substituted diphenyl leukotriene antagonists
WO2001034198A2 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
JP2001247459A (ja) 2000-03-03 2001-09-11 Oakland Uniservices Ltd 癌の組み合わせ療法
WO2001085166A1 (en) * 2000-05-09 2001-11-15 Creighton University Methods for inhibiting proliferation and inducing apoptosis in cancer cells
AU2001282717A1 (en) 2000-07-28 2002-02-13 Cancer Research Technology Limited Cancer treatment by combination therapy
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
DE602005024384D1 (de) 2004-05-05 2010-12-09 High Point Pharmaceuticals Llc Neue verbindungen, ihre herstellung und verwendung
US8053598B2 (en) 2004-05-05 2011-11-08 High Point Pharmaceuticals, Llc Compounds, their preparation and use
CN1302782C (zh) * 2005-01-17 2007-03-07 北京京卫燕康药物研究所有限公司 盐酸吉西他滨溶液型注射剂
ES2372617T3 (es) 2005-06-30 2012-01-24 High Point Pharmaceuticals, Llc Ácidos fenoxiacéticos como activadores de ppar-delta.
CN103224477A (zh) 2005-12-22 2013-07-31 高点制药有限责任公司 作为PPAR-δ活化剂的苯氧基乙酸
US7943612B2 (en) 2006-03-09 2011-05-17 High Point Pharmaceuticals, Llc Compounds that modulate PPAR activity, their preparation and use
JP5207972B2 (ja) 2006-10-12 2013-06-12 株式会社医薬分子設計研究所 カルボン酸誘導体
US8633245B2 (en) 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor
WO2014060381A1 (de) 2012-10-18 2014-04-24 Bayer Cropscience Ag Heterocyclische verbindungen als schädlingsbekämpfungsmittel
CN104884449A (zh) 2012-10-31 2015-09-02 拜尔农作物科学股份公司 作为害虫防治剂的新的杂环化合物
CN103319466B (zh) * 2013-07-04 2016-03-16 郑州大学 含香豆素母核的1,2,3-三唑-氨基二硫代甲酸酯化合物、制备方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation

Also Published As

Publication number Publication date
AU1599001A (en) 2001-06-06
CZ20021551A3 (cs) 2003-02-12
JP2003513916A (ja) 2003-04-15
NO20022245L (no) 2002-07-09
EA200200545A1 (ru) 2002-12-26
AR032432A1 (es) 2003-11-12
ZA200202822B (en) 2003-09-23
AU778829B2 (en) 2004-12-23
KR20020069512A (ko) 2002-09-04
NO20022245D0 (no) 2002-05-10
NZ517667A (en) 2004-05-28
WO2001034137A3 (en) 2002-02-14
HK1050132A1 (zh) 2003-06-13
SK6492002A3 (en) 2003-09-11
MXPA02004733A (es) 2002-08-30
WO2001034137A2 (en) 2001-05-17
HUP0204449A2 (hu) 2003-04-28
CA2391416A1 (en) 2001-05-17
CN1390139A (zh) 2003-01-08
PL355172A1 (en) 2004-04-05
PE20010701A1 (es) 2001-07-07
BR0015490A (pt) 2002-07-09
EP1231938A2 (en) 2002-08-21
HUP0204449A3 (en) 2006-02-28
IL148579A0 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
TR200201245T2 (tr) Kanser tedavisi için onkolitik kombinasyonlar.
BR0216099B1 (pt) "conjunto de desgaste".
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
ATE293618T1 (de) 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
DE69925133D1 (de) Pyrrolobenzodiazepine
TR200202194T2 (tr) Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri
DE60040981D1 (de) BEHANDLUNG MIT ANTI-ErbB2 ANTIKÖRPERN
TR199800436A3 (tr) Primidin türevlerinin kanserin önlenmesi için kullanilmasi.
ATE231872T1 (de) Thiazolopyrimidinderivate
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
WO2001034198A3 (en) Oncolytic combinations for the treatment of cancer
DE60112960D1 (de) Kondensierte pyridoindolderivate
TR199901017A2 (xx) B�cek ilac� terkibi.
DK1204659T3 (da) Serotonerge benzofuraner
ITRM990426A0 (it) Impiego di inibitori della sostanza p per il trattamento degli adenocarcinomi.
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
WO2001034134A3 (en) Oncolytic combinations for the treatment of cancer
NO20020914D0 (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
ATE250340T1 (de) 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele
ITTO20010222A1 (it) Macchina per il trattamento di olive.
BR0008791A (pt) Derivados anticonvulsivos, úteis no tratamento de tremor essencial
TR200003084T2 (tr) Paroxetine askorbat
IT1320082B1 (it) Procedimento per la realizzazione di reggiseni, nonche' reggisenocosi' ottenuto.
IT248614Y1 (it) Apparecchiatura per l'applicazione in sequenza di coperchietti sulattine o barattoli.
ES1042496Y (es) "pilona sumible".